Pneumonia severity index: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Pneumonia}}
{{Pneumonia}}
{{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com]
{{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com]
{{SK}} PSI, PORT score


==Overview==
==Overview==
The '''[[pneumonia]] severity index [PSI]''' or '''PORT Score''' is a clinical prediction rule that [[medicine|medical practitioners]] can use to calculate the probability of [[morbidity]] and [[death|mortality]] among patients with [[community acquired pneumonia]].<ref name="pmid8995086">Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. ''N Engl J Med''. 1997 Jan 23;336(4):243–250. PMID 8995086</ref>
The pneumonia severity index (PSI) is a clinical prediction rule that [[medicine|medical practitioners]] can use to calculate the probability of [[morbidity]] and [[death|mortality]] among patients with [[community acquired pneumonia]].<ref name="pmid8995086">Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. ''N Engl J Med''. 1997 Jan 23;336(4):243–250. PMID 8995086</ref>


==Development of the PSI==
==Development of the PSI==
The rule uses [[demographics]] (whether someone is older, and is male or female), the coexistence of core morbid illnesses, findings on [[physical examination]] and [[vital signs]], and essential laboratory findings.  This study demonstrated that patients could be stratified into five risk categories, Risk Classes I-V, and that these classes could be used to predict 30-day survival.   
The rule uses [[demographics]] (whether someone is older, and is male or female), the coexistence of core morbid illnesses, findings on [[physical examination]] and [[vital signs]], and essential laboratory findings.  This study demonstrated that patients could be stratified into five risk categories, Risk Classes I-V, and that these classes could be used to predict 30-day survival.   


==Data Source for Derivation & Validation==
==Data Source for Derivation and Validation==
The rule was derived then validated with data from 38,000 patients from the MedisGroup Cohort Study for 1989, comprising 1 year of data from 257 hospitals across the US who used the MedisGroup patient outcome tracking software built and serviced by Mediqual Systems ([[Cardinal Health]]). One significant caveat to the data source was that patients who were discharged home or transferred from the MedisGroup hospitals could not be followed at the 30-day mark, and were therefore assumed to be "alive" at that time.  Further validation was performed with the Pneumonia Patient Outcomes Research Team [PORT] (1991) cohort study.  This categorization method has been replicated by others<ref name="pmid15808136">{{cite journal |author=Aujesky D, Auble TE, Yealy DM, ''et al'' |title=Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia |journal=Am. J. Med. |volume=118 |issue=4 |pages=384-92 |year=2005 |pmid=15808136 |doi=10.1016/j.amjmed.2005.01.006}}</ref> and is comparable to the [[CURB-65]] in predicting mortality.<ref name="pmid15808136">{{cite journal |author=Aujesky D, Auble TE, Yealy DM, ''et al'' |title=Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia |journal=Am. J. Med. |volume=118 |issue=4 |pages=384-92 |year=2005 |pmid=15808136 |doi=10.1016/j.amjmed.2005.01.006}}</ref>
The rule was derived then validated with data from 38,000 patients from the MedisGroup Cohort Study for 1989, comprising 1 year of data from 257 hospitals across the US who used the MedisGroup patient outcome tracking software built and serviced by Mediqual Systems ([[Cardinal Health]]). One significant caveat to the data source was that patients who were discharged home or transferred from the MedisGroup hospitals could not be followed at the 30-day mark, and were therefore assumed to be "alive" at that time.  Further validation was performed with the Pneumonia Patient Outcomes Research Team [PORT] (1991) cohort study.  This categorization method has been replicated by others<ref name="pmid15808136">{{cite journal |author=Aujesky D, Auble TE, Yealy DM, ''et al'' |title=Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia |journal=Am. J. Med. |volume=118 |issue=4 |pages=384-92 |year=2005 |pmid=15808136 |doi=10.1016/j.amjmed.2005.01.006}}</ref> and is comparable to the [[CURB-65]] in predicting mortality.<ref name="pmid15808136">{{cite journal |author=Aujesky D, Auble TE, Yealy DM, ''et al'' |title=Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia |journal=Am. J. Med. |volume=118 |issue=4 |pages=384-92 |year=2005 |pmid=15808136 |doi=10.1016/j.amjmed.2005.01.006}}</ref>



Revision as of 16:33, 23 February 2015

Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumonia severity index On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumonia severity index

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumonia severity index

CDC onPneumonia severity index

Pneumonia severity index in the news

Blogs on Pneumonia severity index

Directions to Hospitals Treating Pneumonia

Risk calculators and risk factors for Pneumonia severity index

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.D. [2]

Synonyms and keywords: PSI, PORT score

Overview

The pneumonia severity index (PSI) is a clinical prediction rule that medical practitioners can use to calculate the probability of morbidity and mortality among patients with community acquired pneumonia.[1]

Development of the PSI

The rule uses demographics (whether someone is older, and is male or female), the coexistence of core morbid illnesses, findings on physical examination and vital signs, and essential laboratory findings. This study demonstrated that patients could be stratified into five risk categories, Risk Classes I-V, and that these classes could be used to predict 30-day survival.

Data Source for Derivation and Validation

The rule was derived then validated with data from 38,000 patients from the MedisGroup Cohort Study for 1989, comprising 1 year of data from 257 hospitals across the US who used the MedisGroup patient outcome tracking software built and serviced by Mediqual Systems (Cardinal Health). One significant caveat to the data source was that patients who were discharged home or transferred from the MedisGroup hospitals could not be followed at the 30-day mark, and were therefore assumed to be "alive" at that time. Further validation was performed with the Pneumonia Patient Outcomes Research Team [PORT] (1991) cohort study. This categorization method has been replicated by others[2] and is comparable to the CURB-65 in predicting mortality.[2]

Usage & Application of the PSI

The purpose of the PSI is to classify the severity of a patient's pneumonia to determine the amount of resources to be allocated for care. Most commonly, the PSI scoring system has been used to decide whether patients with pneumonia can be treated as outpatients or as (hospitalized) inpatients. A Risk Class I pneumonia patient can be sent home on oral antibiotics. A Risk Class II-III pneumonia patient may be sent home with IV antibiotics or treated and monitored for 24 hours in hospital. Patients with Risk Class IV-V pneumonia patient should be hospitalized for treatment.

The PSI Algorithm

The PSI Algorithm is detailed below. An online, automated PSI calculator is available on the US AHRQ website.

 
 
 
Step 1

Does the patient has any of the following conditions?

  • >50 years of age
  • Altered mental status
  • Pulse ≥125/minute
  • Respiratory rate >30/minute
  • Systolic blood pressure ≥90 mm Hg
  • Temperature <35°C or ≥40°C
  • Neoplastic disease
  • Congestive heart failure
  • Cerebrovascular disease
  • Renal disease
  • Liver disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
Risk Class I
 
 
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 2
Assess the following conditions and assign the corresponding scores:
Condition Points
If Male+Age (yrs)
If Female+Age (yrs) - 10
Nursing home resident +10
Neoplastic disease +30
Liver disease +20
Congestive heart failure +10
Cerebrovascular disease +10
Renal disease +10
Altered mental status+20
Pulse ≥125/minute +20
Respiratory rate >30/minute +20
Systolic blood pressure ≥90 mm Hg +15
Temperature <35°C or ≥40°C +10
Arterial pH <7.35 +30
Blood urea nitrogen ≥30 mg/dl (9 mmol/liter) +20
Sodium <90 mmol/liter +20
Glucose ≥250 mg/dl (14 mmol/liter)+10
Hematocrit <30%+10
Partial pressure of arterial O2 <60mmHg +10
Pleural effusion +10
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
∑ <70 = Risk Class II
 
∑ 71-90 = Risk Class III
 
∑ 91-130 = Risk Class IV
 
∑ >130 = Risk Class V
 

PSI Derivation and Validation Data

Medisgroup Study (1989) PORT Validation Study (1991) Cohort
Derivation Cohort Validation Cohort Inpatients Outpatients All Patients
Risk Class no. of pts % died no. of pts % died no. of pts % died no. of pts % died no. of pts % died
I 1,372 0.4 3,034 0.1 185 0.5 587 0.0 772 0.1
II (<70) 2,412 0.7 5,778 0.6 233 0.9 244 0.4 477 0.6
III (71–90) 2,632 2.8 6,790 2.8 254 1.2 72 0.0 326 0.9
IV (91–130) 4,697 8.5 13,104 8.2 446 9.0 40 12.5 486 9.3
V (>130) 3,086 31.1 9,333 29.2 225 27.1 1 0.0 226 27.0
Total 14,199 10.2 38,039 10.6 1343 8.0 944 0.6 2287 5.2

Note: % Died refers to 30-day mortality.

References

  1. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan 23;336(4):243–250. PMID 8995086
  2. 2.0 2.1 Aujesky D, Auble TE, Yealy DM; et al. (2005). "Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia". Am. J. Med. 118 (4): 384–92. doi:10.1016/j.amjmed.2005.01.006. PMID 15808136.

External Links

Template:WH Template:WS